During the period 2001 to 2008, a total of 7,872 equine sera were tested at the Athens Centre of Veterinary Institutes. Antibodies against seven infectious diseases of equids were determined: equine infectious anaemia (EIA), African horse sickness (AHS), equine viral arteritis (EVA), West Nile encephalitis (WNE), glanders, piroplasmosis and dourine. Tests for the four viral diseases found 4.5% seropositivity for EIA, 0% for AHS, 3.3% for EVA and 4% for WNE. All sera tested for glanders antibodies were negative. Tests for piroplasmosis detected antibodies against T. equi and B. caballi in 12.9% and 1.3% of the sera, respectively. No sample tested positive for dourine. The results of this epidemiological survey provide strong evidence that Greece is free from the diseases of AHS, glanders and dourine. Rev. sci. tech. Off. int. Epiz., 32 (3) 24102013-00012-EN 2/31
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Equine infectious anaemia
Equine infectious anaemia (EIA) is a viral disease found on all continents, caused by an RNA virus of the genus Lentivirus of the family Retroviridae (4, 5). The disease can be transmitted vertically or horizontally: by the intrauterine route and by suckling, through the use of infected surgical equipment, mechanically by the bite of bloodRev. sci. tech. Off. int. Epiz., 32 (3) 24102013-00012-EN 3/31 feeding insects, and from the nasal mucosa or from skin lesions (traumatic ruptures of the skin). The virus is found in all tissues and secretions of the animals, with higher concentrations in the spleen and lymph nodes.
Clinical signs include weakness, loss of appetite, depression, jaundice, anaemia, oedema, transient fever and mucosal petechiae. The morbidity of the disease is variable but can reach 100% where there is a very high concentration of animals (6). Those animals that survive the infection become life-long carriers of the virus. The disease has been notifiable in Greece since 1960 (6).
African horse sickness
African horse sickness (AHS) is caused by an RNA virus of the genus
Orbivirus of the family Reoviridae (1, 5, 7) . There are nine serotypes of the virus, which is transmitted via biting midges of the genus Culicoides. Infection is characterised by high fever, dyspnoea, circumocular and inframandibular oedema, swelling in the chest and neck, and ultimately death.
Haemorrhages are noticeable at necropsy, together with pulmonary oedema and exudate. Petechiae are found in the small and large intestine, and bleeding in the heart and lungs. The virus can be isolated from whole blood samples collected with anticoagulant and from the spleen and lymph nodes.
The disease is enzootic in Africa, south of the Sahara desert (1, 8) , and appeared in North Africa in 1928 , 1943 and 1944 , in the Middle East and Cyprus in 1959 and 1960 , and in Spain between 1987 and 1990 . It has not been found in Greece, even though it belongs to the same group as bluetongue and is transferred by the same vector, Culicoides imicola, which has been found in both mainland Greece and the Aegean Islands. African horse sickness is notifiable. 
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Equine viral arteritis
Glanders
Glanders is caused by the bacterium Burkholderia mallei (13) and horses, donkeys and mules are susceptible to the infection. Bovines, sheep, goats and pigs are considered resistant. Canines can be infected through eating infected meat, whereas felines appear to be more resistant.
The bacterium is transmitted through secretions of the digestive and respiratory system, as well as through the skin. Humans can be infected by direct contact with a sick animal or infectious materials.
The incubation period lasts from a few days to months. The acute form of glanders appears mostly in donkeys, with high fever, respiratory signs (dyspnoea, pneumonia) and death after a few days.
Horses demonstrate two chronic forms:
a) the respiratory form (glanders), with nodules and ulcers in the nasal cavities and lungs, thick nasal secretions, hyperplasia of the inframandibular lymph nodes, cough, dyspnoea, fever and depression b) the cutaneous form (farcy), with nodules and ulcers in the lymphatic vessels of the limbs and body.
A subclinical form of glanders without any characteristic signs, apart from nasal excretion and fatigue, is also common in horses and is considered responsible for maintaining the pathogen in the environment and the occurrence of epidemics (13). Mules usually present with the acute or subacute forms, although there have been reports of some chronic and subclinical forms (14). 
Materials and methods
The study involved all 51 prefectures of Greece and was implemented: at sampling a minimum 5% of the total equine population over 12 months of age.
[ 
West Nile encephalitis
Samples were tested in a serum neutralisation assay in cultures of Vero E6 cells.
Glanders
Sera were tested for glanders (B. mallei) using a complement fixation assay with reagents from the National Veterinary Services
Laboratories USA (NVSL-USA), and the United States Department of Agriculture, Animal and Plant Health Inspection Service (USDA-APHIS). Where results were inconclusive, local veterinarians collected further blood samples and sent them to the microbiology laboratory for repeat testing; this was followed by clinical examination of all equids at the holding of origin.
Equine piroplasmosis
Samples were tested for piroplasmosis (T. 
Results
Equine infectious anaemia
A total of 7,872 equine sera from animals in 49 prefectures of Greece were tested for EIA, of which 353 (4.5%) were seropositive (Table II) .
African horse sickness
A total of 7,661 sera from 49 prefectures were tested and one sample was found to have borderline ELISA values for AHS antibody (Table   II) .
[ Table II ]
Equine viral arteritis
A total of 7,579 equine sera from 49 prefectures were tested for EVA.
Of these, 249 (3.3%) were positive (Table III) .
West Nile encephalitis
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A total of 7,549 equine sera from 49 prefectures were tested for WNE antibody, among which 302 (4.0%) were positive and 1,122 were toxic (Table III) .
[ Table III ]
Glanders
A total of 7,697 equine sera from 49 prefectures were tested for glanders. Antibodies were initially detected in one horse from the region of Rodopi (Table IV) . The suspect case was retested but with negative results. Supplementary sampling of the associating animals gave negative results for all sera.
[ Table IV ]
Equine piroplasmosis
A total of 2,685 equine sera from 41 prefectures were tested for piroplasmosis. Antibodies to T. equi (B. equi) were detected in 347 sera (12.9%); antibodies to B. caballi were detected in 35 sera (1.3%) (Table V) .
[ Table V ]
Dourine
A total of 1,091 equine sera from animals in 29 prefectures were tested for dourine antibodies, all with negative results (Table VI) .
[ Table VI ]
Tests on horses imported into Greece
Among 654 samples from imported animals, one tested positive for EIA, two for WNE and 48 for EVA. There were no positive results for AHS or glanders (Table VII) .
African horse sickness
Greece is considered a country free of AHS. Antibodies were detected in only one animal, an old horse in Pieria that had been bought in Karditsa but had originally come from Spain, where all equines received preventive vaccination during the AHS epidemic there (26, 27 ). An attempt to isolate the virus was negative and it was concluded that the detected antibodies were the result of the earlier vaccination.
All the animals in the same stable were tested and all were found negative for AHS. The authors found significant variation between the results of the serum neutralisation test and those of the ELISA. The rate of EVA seropositivity found when using the ELISA was extremely high, and a comparative study is needed to evaluate the diagnostic ability of ELISA kits. Equine transportation and the world trade in horses make a fast and reliable method of antibody detection a necessity.
Equine viral arteritis
West Nile encephalitis
Tests for WNE detected antibodies in 36 of the 49 contributing 
Glanders
The authors' results show that glanders does not exist in Greece;
antibodies were detected in only a single asymptomatic animal in the area of Rodopi. When evaluating that case, three possible explanations were considered:
24102013-00012-EN 14/31 a) a false-positive result: this is a problem with the complement fixation test because of the nature of the non-purified antigen (13, 32, 33) and the quality of the serum (immune complexes) b) a cross-reaction with bacteria of the genera Pseudomonas and
Burkholderia (34) c) chronic subclinical disease: an unlikely explanation because of the young age of the animal and the absence of other seropositive animals in the same stable.
Equine piroplasmosis
Antibodies against the organisms causing piroplasmosis were detected in samples from 39 of the 41 submitting prefectures, suggesting that the disease is widely spread through many regions of Greece. There were very high rates of seropositivity for T. equi, which is considered more infectious than B. caballi (19, 34, 35) . In general, piroplasmosis Rev. sci. tech. Off. int. Epiz., 32 (3) 24102013-00012-EN 15/31
International trading of equines
Many of the animals that are transported through Greece have antibodies for EVA and WNE (Table VII) . According to the legislation, stallions used for breeding are not allowed to enter the country if found to be seropositive for EVA. Strict adherence to the veterinary hygiene regulations governing the movement of equines should be sufficient to prevent problems now and in the future.
Conclusions
This epizootiological survey of seven important diseases of horses identified antibodies to four of these diseases in serum samples collected from many areas of Greece. The authors conclude that the country is free from glanders, dourine and AHS. In the case of dourine, however, a larger number of samples should be examined to gain a more thorough understanding of the situation of this disease in Greece. 
Greek prefectures
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